Skip to main content
Microbial Genomics logoLink to Microbial Genomics
. 2021 Nov 30;7(11):000693. doi: 10.1099/mgen.0.000693

SARS-CoV-2 variants of concern dominate in Lahore, Pakistan in April 2021

Muhammad Bilal Sarwar 1,, Muhammad Yasir 2,, Nabil-Fareed Alikhan 2,*, Nadeem Afzal 1, Leonardo de Oliveira Martins 2, Thanh Le Viet 2, Alexander J Trotter 2, Sophie J Prosolek 2, Gemma L Kay 2, Ebenezer Foster-Nyarko 2, Steven Rudder 2, David J Baker 2, Sidra Tul Muntaha 1,3, Muhammad Roman 1, Mark A Webber 2,4, Almina Shafiq 1, Bilquis Shabbir 5, Javed Akram 1, Andrew J Page 2, Shah Jahan 1,*
PMCID: PMC8743565  PMID: 34846280

Abstract

The SARS-CoV-2 pandemic continues to expand globally, with case numbers rising in many areas of the world, including the Indian sub-continent. Pakistan has one of the world’s largest populations, of over 200 million people and is experiencing a severe third wave of infections caused by SARS-CoV-2 that began in March 2021. In Pakistan, during the third wave until now only 12 SARS-CoV-2 genomes have been collected and among these nine are from Islamabad. This highlights the need for more genome sequencing to allow surveillance of variants in circulation. In fact, more genomes are available among travellers with a travel history from Pakistan, than from within the country itself. We thus aimed to provide a snapshot assessment of circulating lineages in Lahore and surrounding areas with a combined population of 11.1 million. Within a week of April 2021, 102 samples were sequenced. The samples were randomly collected from two hospitals with a diagnostic PCR cutoff value of less than 25 cycles. Analysis of the lineages shows that the Alpha variant of concern (first identified in the UK) dominates, accounting for 97.9 % (97/99) of cases, with the Beta variant of concern (first identified in South Africa) accounting for 2.0 % (2/99) of cases. No other lineages were observed. In depth analysis of the Alpha lineages indicated multiple separate introductions and subsequent establishment within the region. Eight samples were identical to genomes observed in Europe (seven UK, one Switzerland), indicating recent transmission. Genomes of other samples show evidence that these have evolved, indicating sustained transmission over a period of time either within Pakistan or other countries with low-density genome sequencing. Vaccines remain effective against Alpha, however, the low level of Beta against which some vaccines are less effective demonstrates the requirement for continued prospective genomic surveillance.

Keywords: ARTIC, genomic epidemiology, genome, NGS, sequencing, SARS-CoV-2

Data Summary

Consensus genomes are available from GISAID (Shu and McCauley, 2017) subject to minimum quality control criteria, with individual sample accession numbers in Table S1, available in the online version of this article). Raw reads and consensus genomes are available from European Nucleotide Archive (ENA) in Bioproject PRJEB45462. Individual sample accession numbers for each database are listed in Table S1. Anonymized metadata was available to all authors and is deposited along with the genomic data in GISAID and the ENA and is provided in Table S1. Supplementary Material can be found in Figshare: https://doi.org/10.6084/m9.figshare.16553199.v1 [1].

Impact Statement.

Genome sequencing of SARS-CoV-2 helps public health scientists to understand the dynamics of the pandemic in different parts of the world. Low- and middle-income countries have low levels of genomic surveillance, depriving them of effective data sources to manage their pandemic response and set public health policy. We provide a snapshot of samples taken over 1 week from Lahore, Pakistan and find that all of the samples sequenced were variants of concern, which have either increased transmissibility or reduced efficacy against vaccines. The 102 samples sequenced represented a fold increase in the number of genomes available for Pakistan (at the time of sequencing).

Introduction

The COVID-19 pandemic has spread rapidly throughout the world and continues to expand in many regions. It began with an unknown case of pneumonia in the city of Wuhan, PR China [2]. The causative pathogen has since been named ‘severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2)’. As of May 2021, there have been over 167 million reported cases and 3.4 million fatalities [3]. Genomic surveillance has assisted the pandemic response providing information for outbreak investigations and detecting possible epitope changes that would allow the virus to escape vaccines. Multiple classification systems have been developed to quickly communicate SARS-CoV-2 variants circulating in a community [4–6]. From these definitions, certain lineages have been designated as variants of concern (VOCs), which are defined as such due to indications of increased transmission patterns and/or possible resistance to vaccine and/or other treatments [7]. The World Health Organisation (WHO) has introduced a new nomenclature of these VOCs and variants of Interest (VOIs) based on Greek alphabets.

B.1.1.7 (Alpha) and B.1.351 (Beta) are two VOCs that have circulated globally. The SARS-CoV-2 lineage B.1.1.7, designated variant of concern 202012/01 (VOC) by Public Health England, was first identified in the UK in late Summer to early Autumn 2020 [7]. B.1.351 is another VOC identified in South Africa and defined by eight mutations in the spike protein including (K417N, E484K and N501Y) [8].

Pakistan is currently experiencing a severe third wave of infections caused by SARS-CoV-2, which began in March 2021. Vaccination rates nationally are under 2 % [9], leaving large segments of the community at risk of serious illness from COVID-19. Currently very few SARS-CoV-2 genomes collected in Pakistan are available, with just 12 covering the third wave, nine of which are from one city, Islamabad. This highlights the need for more genome sequencing from Pakistan, particularly given the current situation and the very high population in order to allow surveillance of variants in circulation. Currently, more genomes are available in the GISAID database for travellers with a travel history from Pakistan, than from within the country itself [10].

We have amplicon sequenced 102 samples, randomly chosen from a 1 week period in April 2021 from Lahore and surrounding areas, to get a snapshot assessment of the circulating lineage in the region. This has identified the Alpha variant of concern as the primary lineage circulating, found in 97.9 % of cases, with clear signals of repeated overseas introductions into the region.

Methods

Genome sequencing and analysis

RNA was extracted using Viral RNA Extraction kit, FavorPrep (Cat. No. FAVNK 001–1) and and detection was carried out on IQ5five real time PCR using GenomeCoV19 Detection Kit by abm (cat: 628) in facility of resource lab for research in biomedical sciences and COVID-19 research lab of University of Health Sciences, Lahore, Pakistan.

Positive samples with a CT <25 were randomly selected for genome sequencing. Viral RNA was converted in cDNA (SuperScript III) and was amplified using the ARTIC protocol v3 (LoCost) [11] with sequencing libraries prepared using CoronaHiT [12]. We carried out genome sequencing using the Illumina NextSeq 500 platform.

The raw reads were demultiplexed using bcl2fastq (v2.20). The reads were used to generate a consensus sequence using the ARTIC bioinformatic pipeline [13]. Briefly, the reads had adapters trimmed with TrimGalore [14] and were aligned to the WuhanHu-1 reference genome (accession MN908947.3) using BWA-MEM (v0.7.17) [15]; the ARTIC amplicons were trimmed and a consensus built using iVAR (v.1.2.3) [16].

PANGO lineages assigned using Pangolin v2.4.2 and PangoLEARN model dated 12 May 2021 [6, 17].

Phylogenetic analysis

For the phylogenetic analysis, all sequences from GISAID (available on 14 May 2021) where Pakistan is the country of exposure were downloaded and added to the sequences from the current study. From these 268 samples, 131 were sequenced outside Pakistan, with 110 from the Airport Quarantine Station in Japan (travellers from Pakistan sampled at arrival) [18]. All remaining sequences from GISAID were then compared to this data set where we kept the closest ones – for each Pakistan sequence, the four closest from non-Pakistan were kept for subsequent analysis to provide context. The alignment and neighbour search were done with uvaia [19], and problematic (homoplasic or difficult to sequence) sites were masked from the alignment [20]. For the B.1.1.7 (Alpha) and B.1.351 (Beta) dated phylogenetic inference, we further enriched each alignment with more distant neighbours, which maximized the phylogenetic diversity [21], based on the neighbour-joining tree [22] of all sequences close to each Pakistan sequence, for each lineage. Sequences with more than 10 % N, or with incomplete date information were excluded from analysis. Clusters distant and unrelated to Pakistan sequences were reduced or removed by visual inspection of maximum-likelihood trees.

From the 102 UHS-PAK sequences, 90 samples were included in the phylogenetic analysis: 88 from Alpha and 2 samples from Beta; the final alignments have 723 and 107 sequences, respectively. The maximum-likelihood trees were inferred with IQTREE2 v2.1.2 [23] with 1000 ultrafast bootstrap replicates [24]. The divergence times were estimated by marginalization under a relaxed clock using TreeTime [25] and assuming a coalescent prior on three lengths with a constant effective population size. Polytomies were resolved by treetime when possible by using the time information. Ancestral state reconstruction of the country of exposure was done under parsimony over the timed tree with castor [26] and trees were plotted with ggtree [27], both for R. By weighting reconstructed states (countries of exposure) at the internal nodes by the number of most parsimonious scenarios, castor gives the probability of each node belonging to Pakistan or abroad. The number of introductions into Pakistan was estimated by counting branches where the reconstructed probability of being exposed in Pakistan increased to one. Equivalently, the exportations out of Pakistan were given by branches with a parental node most probably from Pakistan (prob >0.5) and a child node certainly not from Pakistan (prob=0). We assume that the date of the event is given by the parental node, to discount for ‘importation’ and ‘detection’ lags [28], and thus may be biassed since the true transition happened somewhere along the branch (i.e. more recent than our estimate). For this analysis we excluded the 21 Pakistani samples sequenced outside Pakistan, which might have been circulating abroad (i.e. except those from the Japanese Airport Quarantine Station). Notice that if the parsimony assumption fails, e.g. if we expect frequent international transmission events hidden along nodes in the tree, then this should be modelled under a probabilistic (likelihood or Bayesian) approach. Since we included the closest sequences from abroad, the reconstruction should not change by adding more available data. However, due to unequal sampling and sequencing, the number of transitions is an underestimate and their dates are subject to selection bias (e.g. previous introductions were not sequenced due to regional differences or severity of infection).

The distances between all leaf pairs along the maximum-likelihood tree were calculated with the package ape for R. These so-called patristic (or cophenetic) distances describe the path length along all branches separating two samples, and by taking the phylogeny into account are a better descriptor of the evolutionary differences between the sequences. By multiplying the patristic distances by genome length we obtain the expected number of SNP differences between samples, since branch lengths in a maximum-likelihood tree are given in ‘expected substitutions per site’.

Results and discussion

In this study, from 6 April 2021 to 11 April 2021, 102 SARS-CoV-2 samples in viral transport medium (VTM) were randomly selected from SARS-CoV-2 diagnostic positives by the Mayo Hospital and Sheikh Zayed Hospital in Lahore, Pakistan. All samples had a Ct <25. These public hospitals serve a predominantly middle-income population. The cases were between 21 and 91 years of age with a broad distribution of ages, with 74 % (n=74) male, 26 % (n=26) female and two unknown. Four samples were from cases who died (all aged over 60), while all others recovered. Cases had no history of international travel, with 77 cases explicitly reporting that they and their household did not recently travel overseas (Table S1).

Viral RNA was amplified using the ARTIC protocol [11] with sequencing libraries prepared using CoronaHiT [12]. Resulting sequenced reads were used to generate consensus sequences with the ARTIC bioinformatics protocol (see Methods).

Analysis of the PANGO lineages shows that B.1.1.7 (Alpha) (first identified in the UK) dominates, accounting for 97.9 % (97/99) of cases, with B.1.351 (Beta) (first identified in South Africa) accounting for 2.0 % (2/99) of cases. Three further samples failed QC, yielding genomes less than 50 % coverage of SARS-CoV-2, and lineages could not be confidently called. No other lineages were observed.

SARS-CoV-2 was first identified in Pakistan on 26 February 2020 [29]. The first Alpha genome was submitted to GISAID on 25 December 2020. There were previously 268 SARS-CoV-2 genomes available on GISAID where Pakistan was listed as the country of exposure with 90 assigned as Alpha or Beta (Tables 1 and S1). Most of these samples were associated with international travel from the country and were collected outside of Pakistan (Table S2). A list of submitting authors of these data can be found in Table S3. We combined all Alpha and Beta public data with the genomes presented in this study to provide a snapshot of Alpha and Beta dissemination (Table S4).

Table 1.

PANGO lineages of GISAID (as of 2020-05-14) data where Pakistan is the country of exposure, with collection dates of first and most recent samples

Lineage

Count

Oldest sample

Most recent sample

Lineage

Count

Oldest sample

Most recent sample

B.1.1.7 (Alpha)

87

25 December 2020

27 April 2021

B.1.36.22

1

30 November

B.1.351 (Beta)

3

9 April 2021

26 April 2021

C.23

5

11 May 2020

26 November 2020

B.1.617.1

1

26 April 2021

B.1

30

3 May 2020

24 November 2020

C.36

1

26 March 2021

B.1.36.8

1

24 November 2020

B.1.525

1

19 February 2021

B.1.36.24

3

2020-10-31

13 November 2020

B.1.1

10

11 May 2020

14 February 2021

B.1.459

1

10 October 2020

B.1.36

35

2 June 2020

9 February 2021

B.1.562

1

10 October 2020

B.1.36.31

17

10 October 2020

23 January 2021

B

3

12 March 2020-

2 July 2020

B.1.36.34

5

9 September 2020

11 January 2021

B.1.260

1

2 July 2020

B.1.1.214

1

6 January 2021

C.11

2

3 June 2020

18 June 2020

B.1.523

1

5 January 2021

B.6

12

16 March 2020

14 June 2020

B.1.1.1

18

3 June 2020

14 December 2020

A

3

2 June 2020

3 June 2020

B.1.471

24

20 May 2020

14 December 2020

B.1.1.370

1

28 May 2020

By reconstructing the exposure history over the phylogenetic tree, we estimate the number of Alpha importations as 112 using the dated tree, as well as 11 exports out of the country (Fig. 1). From the histogram at the bottom of Fig. 1, we observe that the first introduction of Alpha into Pakistan may have happened as early as mid October 2020. This is after the date of emergence of Alpha in the UK, which has been calculated as September 2020 elsewhere [30]. There was an increasing number of independent introductions more recently, such that most Alpha samples can be traced back to a recent ancestor abroad, while a few may have been circulating for longer (or belong to unsampled groups).

Fig. 1.

Fig. 1.

Phylogeny of B.1.1.7 (Alpha) including genomes from Pakistan. At the top, the maximum-likelihood dated tree of lineage B.1.1.7 (Alpha), showing only samples close to sequences related to Pakistan. Branches are coloured red when all descendant tips have Pakistan as the country of exposure. Samples sequenced in the present study are highlighted as red dots. At the bottom we have the histogram of introductions into and exportations out of Pakistan over time, as estimated by ancestral state reconstruction. Phylogenetic tree was estimated with IQTREE2 followed by divergence times estimation using TreeTime after excluding outliers. The figure was plotted with ggtree and introduction events were estimated by ancestral reconstruction under parsimony with the R package castor.

Genomes from Pakistan were intermingled with genomes from elsewhere, as shown in Fig. 2 where we calculated the patristic distance of genomes in this study to their closest neighbour and found that they were generally closer to samples from abroad, i.e. samples without a travel history to Pakistan (see also Fig. S5, with the maximum-ikelihood tree). The number of substitutions to the nearest neighbour also varied (0–8 substitutions) (Fig. 2). All samples in this study were sourced from cases with no travel history. The virus is detected and sequenced from the source, usually the UK, where 2 % of the population describe their ethnicity as Pakistani [22] and where there are many daily direct flights, and then in some cases sampled in Pakistan immediately or after several months, where the number of substitutions were lower or higher, respectively.

Fig. 2.

Fig. 2.

Distribution of distances to closest neighbours from Pakistan and abroad, for B.1.1.7 (Alpha) sequences. The number of expected substitutions is calculated from the patristic distances between leaves over the maximum-likelihood tree, transformed from substitutions per site by multiplying by genome length. For each of the 88 UHS-PAK sequences, we find the closest distance considering only Pakistan (blue) or international (red) tips on the tree.

Beta was likely introduced into Pakistan recently. Beta samples were found in four clades in the phylogeny of Beta, suggesting at least four separate introductions into the country (Fig. 3). The time to the most recent common ancestor of Beta globally was calculated here as during September 2020, whereas the clades containing Beta genomes from Pakistan date no earlier than February 2021 (Fig. 3). The date of emergence of Beta is before these dates and has been calculated as early August 2020 elsewhere [8].

Fig. 3.

Fig. 3.

Maximum-likelihood dated tree of lineage B.1.351 (Beta) focused on samples sequenced in this study. Branches are coloured according to country of exposure, with Pakistan highlighted with a red circle. The two samples from the current study, UHS-PAK-S45 and UHS-PAK-S93, are labelled in blue. Phylogenetic tree was estimated with IQTREE2 [23] followed by divergence times estimation using TreeTime after excluding outliers. The figure was plotted with ggtree [27].

It has been demonstrated [31] that vaccines, in particular BNT162b2, are effective against Alpha. Therefore, if this remains the dominant lineage in the region, public health vaccination policy can be implemented accordingly. However, whilst the prevalence of Beta, which has been linked to lower vaccine efficacy, is very low, this reinforces the need for prospective surveillance of SARS-CoV-2 using genome sequencing to inform public health interventions in a continual manner.

The most regular source of genomic sequencing is from travellers from Pakistan being sequenced by their destination countries, and being annotated as such in the public databases (GISAID). Japan is the largest contributor of genomes from travellers originating from Pakistan (111 out of 269). This indirect surveillance is useful but unreliable as travel restrictions and pre-flight testing can bias the results.

This report shows the critical importance of whole-genome sequencing of SARS-CoV-2 to determine the prevalence and changing epidemiology of different variants of the virus. This data is crucial to inform public health decision makers as well as to allow global epidemiology to be understood. Building capacity for sequencing and analysis of genomes in countries with high infection rates will be crucial for the global response to COVID-19.

Supplementary Data

Supplementary material 1
Supplementary material 2
Supplementary material 3
Supplementary material 4
Supplementary material 5

Funding information

The Quadram Institute authors gratefully acknowledge the support of the Biotechnology and Biological Sciences Research Council (BBSRC); their research was funded by the BBSRC Institute Strategic Programme Microbes in the Food Chain BB/R012504/1 and its constituent project BBS/E/F/000PR10352, also Quadram Institute Bioscience BBSRC funded Core Capability Grant (project number BB/CCG1860/1). The University of Health Sciences authors acknowledge the support provided by the Higher Education Commission (HEC) of Pakistan under the project RRG-211.

Conflicts of interest

The authors declare that there are no conflicts of interest.

Ethical statement

This project was conducted under approval number UHS/REG-20/ERC/1758 from the University of Health Sciences Lahore Ethical Review Committee.

Footnotes

Abbreviations: cDNA, complementary DNA; CT, cycle threshold; ENA, European Nucleotide Archive; GISAID, Global Initiative on Sharing Avian Influenza Data; PCR, polymerase chain reaction; RNA, Ribonucleic acid; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; SNP, Single nucleotide polymorphism; UK, United Kingdom; VOCs, variants of concern; VOIs, variants of interest; WHO, World Health Organization.

All supporting data, code and protocols have been provided within the article or through supplementary data files. Four supplementary tables and one supplementary figure are available with the online version of this article.

References

  • 1.Sarwar MB, Yasir M, Alikhan N-F, Afzal N, Oliveira Martins L de. 2021. SARS- cov- 2 variants of concern dominate in lahore, Pakistan in april 2021. Figshare. [DOI] [PMC free article] [PubMed]
  • 2.Huang C, Wang Y, Li X, Ren L, Zhao J, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. doi: 10.1016/S0140-6736(20)30183-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020;20:533–534. doi: 10.1016/S1473-3099(20)30120-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Alm E, Broberg EK, Connor T, Hodcroft EB, Komissarov AB, et al. Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020. Euro Surveill. 2020;25:2001410. doi: 10.2807/1560-7917.ES.2020.25.32.2001410. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Hodcroft EB, Hadfield J, Neher RA, Bedford T. Year-letter Genetic Clade Naming for SARS-CoV-2 on Nextstrain.org. 2020. https://nextstrain.org/blog/2020-06-02-SARSCoV2-clade-naming
  • 6.Rambaut A. A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology. Nat Microbiol. 2020;5:1403–1407. doi: 10.1038/s41564-020-0770-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Transmission of SARS-COV-2 lineage b.1.1.7 in England: Insights from linking epidemiological and genetic data. medRxiv. [Preprint] 2021 doi: 10.1101/2020.12.30.20249034. [DOI] [Google Scholar]
  • 8.Tegally H. Detection of a SARS-CoV-2 variant of concern in South Africa. Nature. 2021;592:438–443. doi: 10.1038/s41586-021-03402-9. [DOI] [PubMed] [Google Scholar]
  • 9.National Command Operation Center Pakistan Cases Details. 2021. https://covid.gov.pk/stats/pakistan
  • 10.Shu Y, McCauley J. GISAID: Global initiative on sharing all influenza data – from vision to reality. Euro Surveill. 2017;22:30494. doi: 10.2807/1560-7917.ES.2017.22.13.30494. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Quick J. NCOV-2019 sequencing protocol v2 v1. protocolsIoBDP7I5RN. 2020 doi: 10.17504/protocols.io.bdp7i5rn. [DOI] [Google Scholar]
  • 12.Baker DJ. CoronaHiT: high-throughput sequencing of SARS-CoV-2 genomes. Genome Med. 2021;13:21. doi: 10.1186/s13073-021-00839-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Artic network. 2018. [ July 6; 2020 ]. https://artic.network/ accessed.
  • 14.Krueger F. UK: The Babraham Institute; 2020. https://github.com/FelixKrueger/TrimGalore [Google Scholar]
  • 15.Li H. USA: Cornell University; 2013. http://arxiv.org/abs/1303.3997 [Google Scholar]
  • 16.Grubaugh ND. An amplicon-based sequencing framework for accurately measuring intrahost virus diversity using PrimalSeq and iVar. Genome Biol. 2019;20:8. doi: 10.1186/s13059-018-1618-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.O’Toole Á. Assignment of epidemiological lineages in an emerging pandemic using the pangolin tool. Virus Evol. 2021;7:veab064. doi: 10.1093/ve/veab064. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Sekizuka T. COVID-19 genome surveillance at international airport quarantine stations in Japan. J Travel Med. 2021;28:taaa217. doi: 10.1093/jtm/taaa217. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.de Oliveira Martins L. UK: Quadram Institute Bioscience; 2021. https://github.com/quadram-institute-bioscience/uvaia [Google Scholar]
  • 20.Turakhia Y. Stability of SARS-CoV-2 phylogenies. PLoS Genet. 2020;16:e1009175. doi: 10.1371/journal.pgen.1009175. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Minh BQ, Klaere S, von Haeseler A. Phylogenetic diversity within seconds. Syst Biol. 2006;55:769–773. doi: 10.1080/10635150600981604. [DOI] [PubMed] [Google Scholar]
  • 22.Simonsen M, Pedersen CNS. Proceedings of the ACM Symposium on Applied Computing. TaiChung, Taiwan: ACM Press; 2011. Rapid computation of distance estimators from nucleotide and amino acid alignments, in proceedings of the 2011 ACM symposium on applied computing - SAC 11. the 2011 ACM symposium; p. 89. p. [Google Scholar]
  • 23.Minh BQ. IQ-TREE 2: new models and efficient methods for phylogenetic inference in the genomic era. Mol Biol Evol. 2020;37:1530–1534. doi: 10.1093/molbev/msaa015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Hoang DT. UFBoot2: Improving the Ultrafast Bootstrap Approximation. Mol Biol Evol. 2018;35:518–522. doi: 10.1093/molbev/msx281. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Sagulenko P, Puller V, Neher RA. TreeTime: Maximum-likelihood phylodynamic analysis. Virus Evol. 2018;4:vex042. doi: 10.1093/ve/vex042. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Louca S, Doebeli M. Efficient comparative phylogenetics on large trees. Bioinformatics. 2018;34:1053–1055. doi: 10.1093/bioinformatics/btx701. [DOI] [PubMed] [Google Scholar]
  • 27.Yu G, Smith DK, Zhu H, Guan Y, Lam T-Y. ggtree: an R package for visualization and annotation of phylogenetic trees with their covariates and other associated data. Methods in Ecology and Evolution Edited by G McInerny. 2017;8:28–36. doi: 10.1111/2041-210X.12628. [DOI] [Google Scholar]
  • 28.du Plessis L. Establishment and lineage dynamics of the SARS-CoV-2 epidemic in the UK. Science. 2021;371:708–712. doi: 10.1126/science.abf2946. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Javed B. Is Pakistan’s response to coronavirus (SARS-CoV-2) adequate to prevent an outbreak? Front Med (Lausanne) 2020;7:158. doi: 10.3389/fmed.2020.00158. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Galloway SE. Emergence of SARS-CoV-2 B.1.1.7 Lineage — United States, December 29, 2020–January 12, 2021’, MMWR. MMWR Morb Mortal Wkly Rep. 2021;70:95–99. doi: 10.15585/mmwr.mm7003e2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Abu-Raddad LJ, Chemaitelly H, Butt AA, National Study Group for COVID-19 Vaccination Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants. N Engl J Med. 2021;385:187–189. doi: 10.1056/NEJMc2104974. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Citations

  1. Sarwar MB, Yasir M, Alikhan N-F, Afzal N, Oliveira Martins L de. 2021. SARS- cov- 2 variants of concern dominate in lahore, Pakistan in april 2021. Figshare. [DOI] [PMC free article] [PubMed]

Supplementary Materials

Supplementary material 1
Supplementary material 2
Supplementary material 3
Supplementary material 4
Supplementary material 5

Articles from Microbial Genomics are provided here courtesy of Microbiology Society

RESOURCES